Skip to main content
Back to News & Events

Vice President Joshua White to Join Panel on the Implications of Teva and Vifor

Event: Informa CompLaw: Pharma Date: 2 December 2025 Host: Informa Location: Brussels, Belgium Times: 11:00–11:40 a.m. (CET)

Vice President Joshua White will participate in  a panel discussion at Informa CompLaw: Pharma, exploring the implications of Teva and Vifor for promotional efforts, internal processes, codes of ethics, and broader compliance practices. Panelists will also address how these developments may influence biosimilar litigations. Mr. White will be joined by Anne Robert (Sidley), Jacob Westin (Sandoz AG), Despoina Samara (GSK), and Aileen Murtagh (Biomarin).

Associated People

Joshua White

Joshua White

Managing Principal

Mr White is a consulting and testifying economist who specialises in applying microeconomics and sophisticated econometric modelling to complex litigation and merger-related questions, primarily in matters involving the health care, financial services and technology industries. He has supported clients in various jurisdictions and industries in follow-on competition damages litigation, assessing overcharge, upstream and downstream pass-on and volume effects. He has served as a testifying expert in the UK Upper Tribunal (Lands Chamber), the UK Competition Appeal Tribunal and the Amsterdam District Court on competition cases.

Mr White has supported high-profile companies with complex merger reviews across multiple jurisdictions, including in the Veolia/Suez, LVMH/Tiffany, Sika/MBCC and Eutelsat/OneWeb mergers. He has also provided evidence to the UK’s Competition and Markets Authority (CMA) and the European Commission (EC), including on behalf of clients involved in cartel investigations, abuse of dominance investigations and mergers. Mr White has also provided support to European financial and competition regulators in coordinated conduct investigations.

Mr White has extensive experience addressing competition and intellectual property (IP) issues in matters related to cutting-edge pharmaceutical products and FRAND licensing questions. As part of this work, he has supported a number of scientific and technical experts in front of courts and regulatory bodies. He also regularly supports pharmaceutical clients on competition issues around market access, pricing, denigration and competition from generic manufacturers.

Mr White has worked in a number of jurisdictions, including the UK, the European Union, Switzerland, Australia, New Zealand, South Africa, Canada, Japan, Korea, the Netherlands, Belgium and the US. His writing has been published in an array of journals, including the Journal of European Competition Law & Practice, the Competition Law Journal and the Journal of Antitrust Enforcement, and he regularly speaks at international competition law and policy conferences.

View Bio
View All Consultants